FDA
label_change
· 2023-03-24
FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approved a supplemental application for ABSORICA LD (isotretinoin) to update its labeling. The sponsor is Sun Pharmaceutical Industries.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ABSORICA LD (ISOTRETINOIN)